SCNLF (Scancell Holdings) Inventory Turnover: 0.00 (As of Oct. 2025)


SCNLF Scancell Holdings PLC SCNLF
20 GF Score
Price $0.28
! 2 Warning Signs
View Full Analysis

What is Scancell Holdings Inventory Turnover?

Scancell Holdings SCNLF 20 Inventory Turnover is 0.00 as of Oct. 2025. GuruFocus rates SCNLF with a GF Score™ of 20/100. The stock has 2 warning signs investors should review.

Inventory Turnover measures how fast the company turns over its inventory within a year. It is calculated as Cost of Goods Sold divided by Total Inventories. Scancell Holdings's Cost of Goods Sold for the six months ended in Oct. 2025 was $0.00 Mil. Scancell Holdings's Average Total Inventories for the quarter that ended in Oct. 2025 was $0.00 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Scancell Holdings  (OTCPK:SCNLF) Inventory Turnover Explanation

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher Inventory Turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Scancell Holdings's Days Inventory for the six months ended in Oct. 2025 is calculated as:

Days Inventory =Average Total Inventories (Q: Oct. 2025 )/Cost of Goods Sold (Q: Oct. 2025 )*Days in Period
=0/0*365 / 2
=

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Scancell Holdings's Inventory to Revenue for the quarter that ended in Oct. 2025 is calculated as

Inventory-to-Revenue=Average Total Inventories (Q: Oct. 2025 ) / Revenue (Q: Oct. 2025 )
=0 / 0
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate Inventory Turnover. An average inventory is a better indication.

Scancell Holdings Inventory Turnover Related Terms

Scancell Holdings Inventory Turnover Historical Data

* Premium members only.

The historical data trend for Scancell Holdings's Inventory Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Scancell Holdings Inventory Turnover Chart

Scancell Holdings Annual Data
Trend Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25
Inventory Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Scancell Holdings Semi-Annual Data
Apr16 Oct16 Apr17 Oct17 Apr18 Oct18 Apr19 Oct19 Apr20 Oct20 Apr21 Oct21 Apr22 Oct22 Apr23 Oct23 Apr24 Oct24 Apr25 Oct25
Inventory Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
SCNLF
20GF Score
Scancell Holdings PLC SCNLF
Inventory Turnover is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Scancell Holdings Inventory Turnover Calculation

Scancell Holdings's Inventory Turnover for the fiscal year that ended in Apr. 2025 is calculated as

Inventory Turnover (A: Apr. 2025 )
=Cost of Goods Sold / Average Total Inventories
=Cost of Goods Sold (A: Apr. 2025 ) / ((Total Inventories (A: Apr. 2024 ) + Total Inventories (A: Apr. 2025 )) / count )
=0.313 / ((0 + 0) / 1 )
=0.313 / 0
=N/A

Scancell Holdings's Inventory Turnover for the quarter that ended in Oct. 2025 is calculated as

Inventory Turnover (Q: Oct. 2025 )
=Cost of Goods Sold / Average Total Inventories
=Cost of Goods Sold (Q: Oct. 2025 ) / ((Total Inventories (Q: Apr. 2025 ) + Total Inventories (Q: Oct. 2025 )) / count )
=0 / ((0 + 0) / 1 )
=0 / 0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Inventory Turnover →
What does a Inventory Turnover of 0.00 mean?
Scancell Holdings (SCNLF) has a Inventory Turnover of 0.00 as of Oct. 2025. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on Scancell Holdings and its competitors.
Is Scancell Holdings' Inventory Turnover too high?
Scancell Holdings' current Inventory Turnover is 0.00. Overall, Scancell Holdings has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Scancell Holdings' Inventory Turnover compare to VRTX and REGN?
Scancell Holdings' Inventory Turnover of 0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventory Turnover for a Biotechnology company?
A good Inventory Turnover depends on the Biotechnology industry context. However, Inventory Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventory Turnover mean?
A high Inventory Turnover can signal that a stock is expensive relative to its fundamentals. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on Scancell Holdings and its competitors. Scancell Holdings's current Inventory Turnover is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Scancell Holdings stock overvalued right now?
Scancell Holdings (SCNLF) has a current Inventory Turnover of 0.00. The current Inventory Turnover is 0.00. Scancell Holdings' overall GF Score™ is 20/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventory Turnover calculated?
Inventory Turnover is calculated from a company's financial statements. For Scancell Holdings (SCNLF), the current Inventory Turnover is 0.00 as of Oct. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Scancell Holdings Business Description

Other Exchanges SCLP:UKSCP:Germany
Address Sanders Road, Unit 202, Bellhouse Building, Oxford Science Park, Oxford, GBR, OX4 4GD
Scancell Holdings PLC is a clinical-stage biotechnology company developing targeted off-the-shelf active immunotherapies to generate safe and long-lasting tumour-specific immunity for a cancer-free future. iSCIB1+, a product from its DNA ImmunoBody platform (AvidiMab), has demonstrated safe, durable, and clinically meaningful benefit as a monotherapy as well as additional benefit when combined with checkpoint therapies in an ongoing Phase 2 trial in melanoma. Modi-1, the peptide immunotherapy from its Moditope platform, is being investigated in a Phase 2 study in a broad range of solid tumours. In addition, the company has established a subsidiary with the intention to hold and develop an early-stage pipeline of high-affinity GlyMab antibodies targeting tumour-specific glycans.
20GF Score

Get the complete analysis for SCNLF

Inventory Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.28
Price